Pneumococcal meningitis epidemics in Africa

Clinical Infectious Diseases

Volumn 43, Issue 6, 2006, Pages 701-703

  Greenwood, Brian ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

AFRICA; BACTERIAL INFECTION; BACTERIAL MENINGITIS; BACTERIAL VIRULENCE; EPIDEMIC; GAMBIA; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; NOTE; PRIORITY JOURNAL; SEASONAL VARIATION; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

BURKINA FASO; CARRIER STATE; DISEASE OUTBREAKS; GHANA; HUMANS; MENINGITIS, PNEUMOCOCCAL; NEISSERIA MENINGITIDIS; SEASONS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 33748288118     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/506943     Document Type: Note

References (16)

1. Lapeyssonnie L. La méniningite cérébro-spinale en Afrique. Bull World Health Organ 1966; 28(Suppl 1):3-114.
2. Greenwood BM. Meningococcal meningitis in Africa. Trans R Soc Trop Med Hyg 1999; 93:341-53.
3. Molesworth AM, Cuevas LE, Connor SJ, Morse AP, Thomson MC. Environmental risk and meningitis epidemics in Africa. Emerg Infect Dis 2003; 9:1287-93.
4. Leimkugel J, Forgor AA, Gagneux S, et al. An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis epidemics. 1 Infect Dis 2005; 192:192-9.
5. Yaro S, Lourd M, Traoré Y, et al. Epidemiological and molecular characteristics of highly lethal epidemic pneumococcal meningitis in Burkina Faso. Clin Infect Dis 2006; 43:693-700 (in this issue).
6. Gagneux S, Hodgson A, Erhard I, et al. Microheterogeneity of serogroup A (subgroup III) Neisseria meningitidis during an outbreak in northern Ghana. Trop Med Int Health 2000; 5:280-7.
7. Gagneux SP, Hodgson A, Smith TA, et al. Prospective study of a serogroup X Neissseria meningitidis outbreak in northern Ghana. J Infect Dis 2002; 185:618-26.
8. Decosas J, Koama JB. Chronicle of an outbreak foretold: meningococcal meningitis W135 in Burkina Faso. Lancet Infect Dis 2002; 2:763-5.
9. Tugwell P, Greenwood BM, Warrell DA. Pneumococccal meningitis: a clinical and laboratory study. Q J Med 1976; 45:583-601.
10. O'Dempsey TJ, McArdle TF, Lloyd-Evans N, et al. Pneumococcal disease among children in a rural area of west Africa. Pediatr Infect Dis J 1996; 15:431-7.
11. Campagne G, Schuchat A, Djibo S, Ousséini A, Cissé L, Chippaux JP. Epidemiology of bacterial meningitis in Niamey, Niger, 1981-96. Bull World Health Organ 1999; 77:499-508.
12. Denis FA, Greenwood BM, Rey JL, et al. Etude multicentrique des sérotypes de pneumocoques en Afrique. Bull World Health Organ 1983; 61:661-9.
13. Adegbola RA, Hill PC, Secka O, et al. Serotype and antimicrobial susceptibility patterns of isolates of Streptococcus pneumoniae causing invasive disease in The Gambia 1996-2003. Trop Med Int Health 2006; 11:1128-35.
14. Bijlmer HA, Van Alphen L, Greenwood BM, Brown J, Hughes A, Menon A. The epidemiology of Haemophilus influenzae meningitis in children under five years of age in The Gambia, West Africa. J Infect Dis 1990; 161:1210-5.
15. Klugman KP, Mahdi SA, Huebner RE, et al. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003; 349:1341-8.
16. Cutts FC, Zaman SM, Enwere G, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia; randomized, double-blind, placebo-controlled trial. Lancet 2005; 365:1139-46.